Carlos Graux, MD, PhD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation. (NCT02017457) | Carlos Graux, MD, PhD | 2013-12-01 |
Track Carlos Graux, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.